David P. Perry 2015 Trust, 10% Owner, See Remarks at Better Therapeutics, Inc. (BTTX), bought 89,156 shares at $2.07 ($184K) on 2022-09-16, disclosed to the SEC on 2022-09-19.
Open-market purchase of $184k BTTX by 10% Owner, See Remarks. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.99 | 10,844 | $22K | 11.7% |
| 2 | $2.07 | 39,156 | $81K | 44.1% |
| 3 | $2.07 | 39,156 | $81K | 44.1% |
| Total | $2.06 avg | 89,156 | $184K | 100% |
| Filing → |